BlackRock Fund Advisors - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 102 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$49,482,000
-0.6%
4,581,672
-5.7%
0.01%
-10.0%
Q3 2016$49,797,000
-15.3%
4,858,275
+7.9%
0.01%
-23.1%
Q2 2016$58,817,000
+173.4%
4,503,620
+130.3%
0.01%
+160.0%
Q1 2016$21,512,000
+20.8%
1,955,613
+1.0%
0.01%
+25.0%
Q4 2015$17,810,000
+25.7%
1,935,853
-5.2%
0.00%0.0%
Q3 2015$14,173,000
-27.3%
2,042,170
+2.9%
0.00%
-20.0%
Q2 2015$19,488,000
+4.4%
1,984,500
-5.8%
0.01%
+25.0%
Q1 2015$18,667,000
+3.7%
2,106,932
+2.6%
0.00%0.0%
Q4 2014$17,997,000
+38.8%
2,054,472
+9.2%
0.00%0.0%
Q3 2014$12,967,000
+28.2%
1,882,050
-2.1%
0.00%
+33.3%
Q2 2014$10,113,000
+1.7%
1,922,620
-12.1%
0.00%0.0%
Q1 2014$9,947,000
-6.3%
2,186,051
+3.8%
0.00%0.0%
Q4 2013$10,611,000
-1.7%
2,105,379
-1.2%
0.00%
-25.0%
Q3 2013$10,799,000
+16.9%
2,129,938
+14.4%
0.00%
+33.3%
Q2 2013$9,236,0001,862,1670.00%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Athos Capital Ltd 284,200$3,126,0001.80%
Nine Chapters Capital Management LLC 13,600$150,0001.42%
Stonepine Capital Management, LLC 216,307$2,379,0001.28%
GLG Partners LP 1,588,897$17,478,0000.97%
MENTA CAPITAL LLC 431,996$4,752,0000.56%
Sapphire Star Partners LP 24,834$273,0000.34%
Yakira Capital Management, Inc. 85,500$941,0000.28%
TFS CAPITAL LLC 55,104$606,0000.24%
BRANT POINT INVESTMENT MANAGEMENT LLC 100,000$1,100,0000.13%
GABELLI & Co INVESTMENT ADVISERS, INC. 102,261$1,125,0000.12%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders